Kidney Transplantation Diagnostics Innovation Study (KTD INNOV)
The KTD INNOV Study contains an unselected deeply phenotyped cohort of kidney transplant recipients and aims to validate the clinical utility of precision diagnostic biomarkers. In 2018–2019, consecutive adult patients who received a kidney allograft were enrolled prospectively at seven French centres and followed-up for a year. Multimodal phenotyping was performed at follow-up visits by collecting clinical, biological, immunological, and histological parameters, and a panel of blood, urinary and kidney tissue biomarkers was analysed. Over 700 kidney transplant recipients (64.1% male and 35.9% female) were included during the study. The median follow-up after transplantation was 12.3 months.
Study design
Biobank
Number of participants at first data collection
733 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
French, European, and United States transplant populations.
Sample features
Country
Year of first data collection
2018
Primary Institutions
National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale, INSERM)
Profile paper DOI
Funders
Agence Nationale de la Recherche (ANR)
Ongoing?
No
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-report questionnaire – unspecified
- None
- None
- None
Engagement
Keywords
